Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Z6VR
|
|||
Former ID |
DNC000357
|
|||
Drug Name |
Buthionine sulfoximine
|
|||
Synonyms |
AC1MS6SH
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Malaria [ICD-11: 1F40-1F45] | Investigative | [1] | |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] | Investigative | [1] | ||
Structure |
Download2D MOL |
|||
Formula |
C8H18N2O3S
|
|||
Canonical SMILES |
CCCCS(=N)(=O)CCC(C(=O)O)N
|
|||
InChI |
1S/C8H18N2O3S/c1-2-3-5-14(10,13)6-4-7(9)8(11)12/h7,10H,2-6,9H2,1H3,(H,11,12)
|
|||
InChIKey |
KJQFBVYMGADDTQ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 5072-26-4
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:28714
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glutamate--cysteine ligase modifier (GCLM) | Target Info | Inhibitor | [1] |
KEGG Pathway | Glutathione metabolism | |||
Metabolic pathways | ||||
Pathwhiz Pathway | Glutamate Metabolism | |||
Glutathione Metabolism | ||||
Cysteine Metabolism | ||||
WikiPathways | Transcriptional activation by NRF2 | |||
NRF2 pathway | ||||
Nuclear Receptors Meta-Pathway | ||||
Metabolism of amino acids and derivatives | ||||
Trans-sulfuration and one carbon metabolism | ||||
Trans-sulfuration pathway | ||||
Phase II conjugation | ||||
Glutathione metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel molecular targets for antimalarial chemotherapy. Int J Antimicrob Agents. 2007 Jul;30(1):4-10. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.